Skip to main content

NUCLEAR MEDICINE PET/CT THYROID CANCER ASSESSMENT, PROTOCOLS, AND INTERPRETATION

Tracking # 20-1061140

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

THYROID CANCER IS OFTEN DESCRIBED AS AN INDOLENT PATHOLOGY WITH A GOOD PROGNOSIS; HOWEVER, POORLY DIFFERENTIATED SUBTYPES DESCRIBE AN AGGRESSIVE BEHAVIOR WITH EXTENSIVE METASTATIC DISEASE AT THE TIME OF DIAGNOSIS. PET/CT HAS BEEN ESTABLISHED AS AN IMPORTANT MODALITY IN THE DETECTION OF POORLY DIFFERENTIATED THYROID CANCER. THIS ACTIVITY REVIEWS THE BIOCHEMICAL BASIS, INDICATIONS, TECHNIQUE, AND CLINICAL SIGNIFICANCE OF PET/CT, HIGHLIGHTING THE INTERPROFESSIONAL TEAM'S ROLE IN EVALUATING AND TREATING PATIENTS WITH THYROID CANCER.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I